ABSTRACT
Metabolic syndrome is highly prevalent worldwide and is considered a public health concern due to its impact on morbidity and mortality as well as on health care costs. Obesity, insulin resistance, hypertension, and atherogenic lipemia are altogether grouped in this entity, which, per se, is a strong risk factor for diabetes and cardiovascular events. The estimated prevalence in the general population is up to 34% (Ford et al. 2010), but it may be higher among vulnerable patients who are in post-liver transplantation stage (Anastacio et al. 2011) and with systemic lupus (Moura dos Santos et al. 2013). It is noteworthy that not only the common associated morbid conditions impact on the subjects’ quality of life but also other not so mentioned conditions, such as periodontal diseases, lead to worse outcomes (Nibali et al. 2013).
